Access cutting-edge chronic spontaneous urticaria treatment through this clinical trial at a research site in Fairborn. Study-provided care at no cost to qualified participants.
Access chronic spontaneous urticaria specialists in Fairborn at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic spontaneous urticaria treatment provided free
The study duration for an individual subject includes screening (14 days), the treatment period (28 days) and the observational follow-up period of 28 days, in total 70 days ± 6 days. All subjects will receive IMP for 28 days followed by one End of Study (EOS) visit, 4 weeks after EOT visit.
Sponsor: InflaRx GmbH
Check if you qualify for this chronic spontaneous urticaria clinical trial in Fairborn, OH
If you're searching for chronic spontaneous urticaria treatment options in Fairborn, OH, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Fairborn research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic spontaneous urticaria specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.